Follow
Soren M Bentzen
Soren M Bentzen
Professor of Epidemiology and Public Health
Verified email at som.umaryland.edu - Homepage
Title
Cited by
Cited by
Year
Use of normal tissue complication probability models in the clinic
LB Marks, ED Yorke, A Jackson, RK Ten Haken, LS Constine, A Eisbruch, ...
International Journal of Radiation Oncology* Biology* Physics 76 (3), S10-S19, 2010
21702010
Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study
GC Barnett, CE Coles, RM Elliott, C Baynes, C Luccarini, D Conroy, ...
The Lancet Oncology, 2011
18222011
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues
SM Bentzen, LS Constine, JO Deasy, A Eisbruch, A Jackson, LB Marks, ...
International Journal of Radiation Oncology* Biology* Physics 76 (3), S3-S9, 2010
14182010
Radiation dose-volume effects in the lung
LB Marks, SM Bentzen, JO Deasy, FMS Kong, JD Bradley, IS Vogelius, ...
International Journal of Radiation Oncology* Biology* Physics 76 (3), S70-S76, 2010
12842010
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
YJR Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM ...
Lancet 371 (9618), 1098-1107, 2008
1232*2008
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
SM Bentzen
Nature Reviews Cancer 6 (9), 702-713, 2006
12312006
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
M Nordsmark, SM Bentzen, V Rudat, D Brizel, E Lartigau, P Stadler, ...
Radiotherapy and Oncology 77 (1), 18-24, 2005
11572005
Overgaard J (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
M Nordsmark, SM Bentzen, V Rudat, D Brizel, E Lartigau, P Stadler, ...
Radiother Oncol 77, 18-24, 0
1157*
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
TS Trialists' Group
The lancet oncology 9 (4), 331, 2008
11472008
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
PD Brown, S Pugh, NN Laack, JS Wefel, D Khuntia, C Meyers, A Choucair, ...
Neuro-oncology 15 (10), 1429-1437, 2013
9702013
Radiation oncology in the era of precision medicine
M Baumann, M Krause, J Overgaard, J Debus, SM Bentzen, J Daartz, ...
Nature Reviews Cancer 16 (4), 234-249, 2016
8772016
Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial
JR Owen, A Ashton, JM Bliss, J Homewood, C Harper, J Hanson, ...
The lancet oncology 7 (6), 467-471, 2006
7832006
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma
J Overgaard, SM Bentzen, DG Gonzalez, M Hulshof, G Arcangeli, O Dahl, ...
The Lancet 345 (8949), 540-543, 1995
7521995
Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial
J Yarnold, A Ashton, J Bliss, J Homewood, C Harper, J Hanson, ...
Radiotherapy and oncology 75 (1), 9-17, 2005
6372005
Theragnostic imaging for radiation oncology: dose-painting by numbers
SM Bentzen
The lancet oncology 6 (2), 112-117, 2005
5322005
Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline
BD Smith, SM Bentzen, CR Correa, CA Hahn, PH Hardenbergh, GS Ibbott, ...
International Journal of Radiation Oncology* Biology* Physics, 2010
5002010
Time-dose factors in radiotherapy: a review of the human data
HD Thames, SM Bentzen, I Turesson, M Overgaard, W Van den Bogaert
Radiotherapy and Oncology 19 (3), 219-235, 1990
4941990
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
R Pötter, K Tanderup, MP Schmid, I Jürgenliemk-Schulz, C Haie-Meder, ...
The Lancet Oncology 22 (4), 538-547, 2021
4412021
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
D De Ruysscher, M Pijls-Johannesma, SM Bentzen, A Minken, ...
Journal of clinical oncology 24 (7), 1057-1063, 2006
4272006
Timing of chest radiation with respect to combination chemotherapy in small cell lung cancer, limited disease
HP Schultz, OS Nielsen, A Sell, S Steenholdt, S Bentzen
Lung Cancer 4, 153, 1988
412*1988
The system can't perform the operation now. Try again later.
Articles 1–20